Boehringer Ingelheim Launches Fast-acting Stroke Medication in the UAE, Reducing Treatment…
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has launched a new acute ischemic stroke (AIS) medication with active ingredient Tenecteplase 25mg to enhance emergency stroke treatment in the UAE, offering a…
Read More...
Read More...